Quinolones Market Report 2026

The quinolones market size has grown steadily in recent years. It will grow from $51.89 billion in 2025 to $54.48 billion in 2026 at a compound annual growth rate (CAGR) of 5%. The growth in the historic period can be attributed to increasing prevalence of bacterial infections, rise in hospital admissions, high demand for broad-spectrum antibiotics, growth of retail pharmacies, government initiatives for infectious disease control.

The quinolones market size is expected to see strong growth in the next few years. It will grow to $66.44 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to advancements in precision medicine, development of novel quinolone formulations, expansion of online pharmacy channels, increasing awareness about antimicrobial stewardship, rising adoption of digital health monitoring tools. Major trends in the forecast period include rising antibiotic resistance management, expansion of generic drug availability, personalized treatment approaches, growth in outpatient and home healthcare services, increased investment in r&d for novel quinolones.

The rising threat of antimicrobial resistance (AMR) is expected to drive the growth of the quinolones market. AMR refers to the ability of microorganisms, such as bacteria, viruses, fungi, and parasites, to resist the effects of antimicrobial drugs. Quinolones, with their broad spectrum of activity, are effective against a wide range of bacteria and are often prescribed when other treatment options are limited. They are able to penetrate various tissues, making them a preferred choice in specific cases of infection. For example, in October 2025, the World Health Organization (WHO) reported a global analysis using data from over 23 million confirmed cases of infections, highlighting the rising prevalence of antibiotic resistance. This trend is expected to fuel the demand for quinolones.

To capitalize on this growing market, major companies are focusing on developing innovative products, such as fluoroquinolone antibiotic eye drops. These eye drops are used to treat bacterial infections of the eye. For instance, in July 2023, Harrow Health Inc., a U.S.-based pharmaceutical company, launched Vigamox, a fluoroquinolone ophthalmic solution containing moxifloxacin hydrochloride. This product is recommended for preventing eye infections both before and after surgery.

In June 2023, Bausch + Lomb Incorporated, a U.S.-based eye health company, acquired Novartis International AG for an undisclosed amount. The acquisition is part of Bausch & Lomb’s strategy to restructure its pharmaceutical division and strengthen its position in the ocular surface disorder market.

Major companies operating in the quinolones market are Bayer AG, Novartis AG, Sanofi SA, Merck & Co. Inc., LG Life Sciences, Pfizer Inc., Viatris Inc., Lupin Limited, Hikma Pharmaceuticals plc, Zydus Group, KYORIN Holdings Inc., Teva Pharmaceutical Industries Ltd., GSK plc, Zee Laboratories, Cipla Ltd., Geo Pharma Pvt. Ltd., Finecure Pharmaceuticals, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Hetero Drugs Ltd., Wockhardt Ltd.

North America was the largest region in the quinolones market in 2025. The regions covered in the quinolones market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the quinolones market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the quinolones market by increasing the cost of imported raw materials and active pharmaceutical ingredients, leading to higher production expenses and supply chain disruptions. The hospital pharmacy and retail pharmacy segments in regions like North America and Europe are most affected. Some manufacturers may benefit by sourcing locally or investing in domestic production, creating opportunities for cost optimization and market resilience.

The quinolones market research report is one of a series of new reports that provides quinolones market statistics, including quinolones industry global market size, regional shares, competitors with a quinolones market share, detailed quinolones market segments, market trends and opportunities, and any further data you may need to thrive in the quinolones industry. This quinolones market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Quinolones are a class of bactericidal antibiotics that work by directly killing bacterial cells, targeting both gram-positive and gram-negative bacteria. They are commonly used to treat a variety of infectious diseases caused by bacterial pathogens.

The main types of quinolones include norfloxacin, ofloxacin, ciprofloxacin, gemifloxacin, and others. Norfloxacin is a fluoroquinolone antibiotic used to treat bacterial infections such as conjunctivitis and urinary tract infections. It targets both gram-positive and gram-negative pathogens. Quinolones like norfloxacin are distributed through various channels, including hospital pharmacies, retail pharmacies, and online pharmacies.

The quinolones market consists of sales of bedaquiline. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.